SNMMI In The News
February 1, 2013
Amyvid backers respond to MEDCAC meeting
DOTMed Business News
Despite a lack of support from an advisory panel, backers of the PET amyloid imaging drug Amyvid are urging the Centers for Medicare and Medicaid Services to evaluate the evidence and provide coverage for the U.S. Food and Drug Administration-approved indication.